Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent vital or major myelin antigenic specificity

Journal of Immunology

Volumn 160, Issue 11, 1998, Pages 5661-5668

  Lin, Xiaoqi ^a,b   Pease, Larry R ^a   Murray, Paul D ^a   Rodriguez, Moses ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MYELIN; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL PARASITOSIS; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; BRAIN INJURY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN CELL; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS ACTIVATION;

ANIMALS; ANTIGENS, CD95; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; CYTOTOXICITY, IMMUNOLOGIC; DISEASE SUSCEPTIBILITY; EPITOPES, T-LYMPHOCYTE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNITY, NATURAL; INJECTIONS, INTRAVENTRICULAR; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; MICE, KNOCKOUT; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; POLIOMYELITIS; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; THEILOVIRUS;

EID: 0032103047     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Clatch, R. J., R. W. Melvold, S. D. Miller, and H. L. Lipton. 1985. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135:1408.
2. Rodriguez, M., J. Leibowitz, and C. S. David. 1986. Susceptibility to Theiler's virus-induced demyelination: mapping of the gene within the H-2D region. J. Exp. Med. 163:620.
3. Lin, X., L. R. Pease, and M. Rodriguez. 1997. Differential generation of class I H-2D- versus H-2K-mediated cytotoxicity in the central nervous system versus spleen determines resistance to virus-induced demyelination. Eur. J. Immunol. 27:963.
4. Lindsley, M. D., and M. Rodriguez. 1989. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J. Immunol. 142:2677.
5. Rodriguez, M., M. D. Lindsley, and M. L. Pierce. 1991. Role of T-cells in resistance to Theiler's virus infection. Microb. Pathog. 11:269.
6. b gene become resistant to persistent infection by Theiler's virus. J. Virol. 68:4049.
7. d tramgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice. J. Neurovirol. 1:111.
8. Fiette, L., C. Aubert, M. Brahic, and C. P. Rossi. 1993. Theiler's virus infection of β2-microglobulin-deficient mice. J. Virol. 67:589.
9. Pullen, L. C., S. D. Miller, M. C. Dal Canto, and B. S. Kim. 1993. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23:2287.
10. b mice deficient in β2-microglobulin. J. Immunol. 151:266.
11. b molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J. Virol. 71:5244.
12. Lin, X., R. Thiemann, L. R. Pease, and M. Rodriguez. 1995. VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 214:91.
13. Rodriguez, M., and S. Sriram. 1988. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J. Immunol. 140:2950.
14. Ausubel, F. M. 1996. Current Protocols in Molecular Biology. John Wiley & Sons, New York, NY.
15. Lehrich, J. R., B. D. Arnason, and F. H. Hochberg. 1976. Demyelinative myelopathy in mice induced by the DA virus. J. Neural. Sci. 29:149.
16. d-reactive monoclonal antibodies recognize shared antigenic determinan(s) on human HLA-B7 or HLA-B27 molecules or both. Immunogenetics 17:357.
17. Oldstone, M., A. Tishon, R. Geckeler, H. Lewicki, and J. L. Whitton. 1992. A common antiviral cytotoxic T-lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination. Proc. Natl. Acad. Sci. USA 89:2752.
18. Lindsley, M. D., R. Thiemann, and M. Rodriguez. 1991. Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J. Virol. 65:6612.
19. 2-microglobulin-dehcient mice. Science 255:1576.
20. 2-microglobulin-deficient mice. Cell Immunol. 173:261.
21. Dethlefs, S., N. Escriou, M. Brahic, S. Van der Werf, and E. L. Larsson. 1997. Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J. Virol. 71:5361.
22. Granco, M., and H. B. Greenberg. 1995. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol. 69:7800.
23. 2-microglobulin-deficient mice. J. Immunol. 153:595.
24. Wekerle, H., K. Kojima, J. Lannes-Vieira, H. Lassmann, and C. Linington. 1994. Animal models. Ann. Neurol. 36:547.
25. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947.
26. Ehl, S., J. Hombach, P. Aichele, H. Hengartner, and R. M. Zinkernagel. 1997. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J. Exp. Med. 185:1241.
27. + T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. USA 91:10859.
28. Miller, S. D., C. L. Vanderlugt, W. S. Begolka, W. Pao, R. L. Yauch, K. L. Neville, Y. Katz-Levy, A. Carrizosa, and B. S. Kim. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3:1133.
29. Miller, S. D., S. J. Gerety, M. K. Kennedy, J. D. Peterson, J. L. Trotter, V. K. Tuohy, C. Waltenbaugh, M. C. Dal Canto, and H. L. Lipton. 1990. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease: failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. J. Neuroimmunol. 26:9.
30. Battegay, M., M. F. Bachmann, C. Burhkart, S. Viville, C. Benoist, C. Mathis, H. Hengartner, and R. M. Zinkernagel. 1996. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain. Cell. Immunol. 167:115.
31. + T lymphocytes and macrophage subsets in the control of a generalized virus infection. J. Virol. 70:8301.
32. Leist, T. P., M. Kohler, and T. M. Zinkernagel. 1989. Impaired generation of anti-viral cytotoxicity against lymphocytic choriomeningitis and vaccinia virus in mice treated with CD4-specific monoclonal antibody. Scand. J. Immunol. 30:679.
33. Jennings, S. R., R. H. Bonneau, P. M. Smith, R. M. Wolcott, and R. Chervenak. 1991. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice. Cell. Immunol. 133:2334.
34. Lin, Y., R. Langman, and M. Cohn. 1992. The priming of cytotoxic T-cell precursors is strictly helper T cell-dependent. Scand. J. Immunol. 35:621.
35. 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells. J. Immunol. 152: 2087.
36. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056.
37. + helper cells. Nature 328:77.
38. + T cells but markedly decreased helper cell activity in mice lacking CD4. Nature 3353:180.
39. + T cell subsets in the control of an acute herpes simplex virus infection of skin and nervous system. J. Gen. Virol. 68:825.
40. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T cell and antibody responses. J. Virol. 62:2102.
41. + T cells. J. Immunol. 144:3980.
42. + T lymphocytes. J. Exp. Med. 169:1199.